Pharmacogenomics articles are devoted to creating investigation, knowledge and information identifying with inquiries of significance in understanding the Pharmacogenomics fields. The global spread of logical society, particularly in late decades, across national limits and with inquire about associations by governments Pharmacogenomics has become a wide research point. Pharmacogenomics diary is devoted to create examination, knowledge and information identifying with inquiries of significance in understanding the field of Pharmacogenomics, Personalized Medicine and Pharmacoproteomics. Pharmacogenomics articles from PrimeOA Publications are an open access diary named as Journal of Pharmacogenomics and Pharmacoproteomics which endeavors to discharge gives every other month. Pharmacogenomics is the investigation of how qualities influence an individual's reaction to drugs. This generally new field joins pharmacology (the study of medications) and genomics (the investigation of qualities and their capacities) to create successful, safe prescriptions and portions that will be custom-made to an individual's hereditary makeup. Many drugs that are as of now accessible are "one size fits all," however they don't work a similar route for everybody. It very well may be hard to anticipate who will profit by a medicine, who won't react by any stretch of the imagination, and who will encounter negative symptoms (called unfriendly medication responses). Unfriendly medication responses are a noteworthy reason for hospitalizations and passings in the United States. With the information picked up from the Human Genome Project, specialists are figuring out how acquired contrasts in qualities influence the body's reaction to meds. These hereditary contrasts will be utilized to anticipate whether a prescription will be compelling for a specific individual and to help forestall unfriendly medication responses. Conditions that influence an individual's reaction to specific medications incorporate clopidogrel opposition, warfarin affectability, warfarin obstruction, harmful hyperthermia, Stevens-Johnson disorder/poisonous epidermal necrolysis, and thiopurine S-methyltransferase inadequacy. The field of pharmacogenomics is still in its outset. Its utilization is as of now very restricted, however new methodologies are under investigation in clinical preliminaries. Later on, pharmacogenomics will permit the advancement of customized medications to treat a wide scope of medical issues, including cardiovascular sickness, Alzheimer malady, malignancy, HIV/AIDS, and asthma.